Requirement of Cytokines for Augmentation of the Antigen-Specific Antibody Responses by Ascorbate in Cultured Murine T-Cell-Depleted Splenocytes.
-
- Mitsuzumi Hitoshi
- Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University
-
- Kusamiya Makoto
- Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University
-
- Kurimoto Takafumi
- Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University
-
- Yamamoto Itaru
- Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University
書誌事項
- タイトル別名
-
- Requirement of Cytokines for Augmentati
この論文をさがす
抄録
To gain a better understanding of the possible mechanisms by which a stable form of ascorbate, ascorbic acid 2-glucoside (AA-2G), as an ascorbate source, augments antibody responses, we examined whether AA-2G enhances the anti-sheep-red-blood-cell (SRBC) plaque-forming cell (PFC) responses elicited with distinct interleukins that provide signals for B-cell proliferation and differentiation in cultured murine T-cell-depleted splenocytes. The anti-SRBC PFC responses were markedly reduced by T-cell depletion; and additions of the concanavalin A-stimulated murine splenocytes supernatant (CAS) or interleukin (IL)-1β, IL-2, IL-5, IL-4 or IL-6 to the culture limitedly restored the immune responses. AA-2G synergistically stimulated the anti-SRBC PFC responses in the presence of IL-1β-, IL-2, IL-5 or CAS, IL-1β among these cytokines being most highly affected. However, it failed to enhance the PFC responses elicited by IL-4 or IL-6. Repeated additions of ascorbic acid (AsA) during experimental periods could also produced the enhancing effect, but a single addition of the vitamin did not, because of its instability in the medium. It was shown that exposure to IL-1β, IL-2 or IL-5 must be done at early times after antigen stimulation of the cells to support their optimal responses and that AsA exerted its effect on day 2 and day 3 after the start of culture. These results suggest that AsA may up-regulate the in vitro IgM antibody responses in a cytokine-dependent manner.
収録刊行物
-
- Jpn.J.Pharmacol.
-
Jpn.J.Pharmacol. 78 (2), 169-179, 1998
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204287076480
-
- NII論文ID
- 10008680697
-
- NII書誌ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK1cXmvFyqs7g%3D
-
- ISSN
- 13473506
- 00215198
-
- NDL書誌ID
- 4591514
-
- PubMed
- 9829620
-
- Web Site
- https://ndlsearch.ndl.go.jp/books/R000000004-I4591514
- https://api.elsevier.com/content/article/PII:S0021519819310455?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S0021519819310455?httpAccept=text/plain
- https://www.jstage.jst.go.jp/article/jjp/78/2/78_2_169/_pdf
- https://search.jamas.or.jp/link/ui/1999065775
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可